Etiology and clinical implications of microvascular dysfunction in patients with acute myocardial infarction

International Heart Journal

Volumn 55, Issue 3, 2014, Pages 185-189

  Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Echocardiography; Microcirculation; Myocardial ischemia; Myocardial perfusion; Myocardial viability; Prognosis; Reperfusion; Ventricular function

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE; CLOPIDOGREL; NICARDIPINE; NICORANDIL; NITRATE; NITROPRUSSIDE SODIUM; OXYGEN RADICAL; PAPAVERINE; VERAPAMIL;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTIFICIAL EMBOLISM; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMANGIOBLAST; HUMAN; ISCHEMIC PRECONDITIONING; MICROVASCULAR DYSFUNCTION; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL CHEMOTAXIS; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION; REVIEW; THROMBOLYSIS IN MYOCARDIAL INFARCTION; THROMBUS ASPIRATION; TISSUE PERFUSION;

CAROTID ARTERY DISEASES; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; ECHOCARDIOGRAPHY; HUMANS; MICROCIRCULATION; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; VENTRICULAR FUNCTION;

EID: 84901505533     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-057     Document Type: Review

References (41)

1. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992; 85: 1699-705.
2. Kaul S, Ito H. Microvasculature in acute myocardial ischemia: part II: evolving concepts in pathophysiology, diagnosis, and treatment. Circulation 2004; 109: 310-5. (Review)
3. Ito H. No-refl ow phenomenon and prognosis in patients with acutemyocardial infarction. Nat Clin Pract Cardiovasc Med 2006; 3: 499-506. (Review)
4. Kloner RA, Ganote CE, Jennings RB. The "no-refl ow" phenomenon after temporary occlusion in the dog. J Clin Invest 1974; 54:1491-508.
5. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223-8.
6. Topol EJ, Yadav JS. Recognition of the importance of emboliza tion in atherosclerotic vascular disease. Circulation 2000; 101: 570-80. (Review)
7. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LW, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes fi rst? Circulation 1980; 62: 945-52.
8. Tanaka A, Kawarabayashi T, Nishibori Y, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 2002; 105: 2148-52.
9. Okamura A, Ito H, Iwakura K, et al. Detection of embolic particles with the Doppler guide wire during coronary intervention inpatients with acute myocardial infarction: effi cacy of distal protection device. J Am Coll Cardiol 2005; 45: 212-5.
10. Yamamoto K, Ito H, Iwakura K, et al. Two different coronary blood fl ow velocity patterns in thrombolysis in myocardial infarction grade 2 in acute myocardial infarction: insight into mechanisms of microvascular dysfunction. J Am Coll Cardiol 2002; 40: 1755-60.
11. Dwivedi G, Janardhanan R, Hayat SA, Swinburn JM, Senior R. Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction. J Am Coll Cardiol 2007; 50: 327-34.
12. Galiuto L, Garramone B, Scarà A, et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling. Results of the multicenter AMICI Study. J Am Coll Cardiol 2008; 51: 552-9.
13. Yano A, Ito H, Iwakura K, Kimura R, et al. Myocardial contrast echocardiography with a new calibration method can estimate myocardial viability in patients with myocardial infarction. J Am Coll Cardiol 2004; 43: 1799-806.
14. Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996; 93: 1993-9.
15. Akasaka T, Yoshida K, Kawamoto T, et al. Relation of phasic coronary fl ow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation 2000; 101: 2361-7.
16. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125-30.
17. Iwakura K, Ito H, Takiuchi S, et al. Alteration in the coronary blood fl ow velocity pattern in patients with no refl ow and reperfused acute myocardial infarction. Circulation 1996; 94: 1269-75.
18. Ito N, Nanto S, Doi Y, et al. Distal protection during primary coronary intervention can preserve the index of microcirculatory resistance in patients with acute anterior ST-segment elevation myocardial infarction. Circ J 2011; 75: 94-8.
19. Matetzky S, Novikov M, Gruberg L, et al. The signifi cance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol 1999; 34: 1932-8.
20. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic signifi cance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-72.
21. de Wahal S, Desch S, Eitel I, et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J 2010; 31: 2660-8.
22. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodelling and improves cardiac function. Nat Med 2001; 7: 430-6.
23. Mongeon FP, Bélisle P, Joseph L, et al. Adjunctive thrombectomy for acute myocardial infarction: A bayesian meta-analysis. Circ Cardiovasc Interv 2010; 3: 6-16.
24. Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction:a comprehensive meta-analysis of randomized trials. Eur Heart J 2008; 29: 2989-3001. (Review)
25. Fröbert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 2013; 369: 1587-97.
26. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005; 293: 1063-72.
27. Gick M, Jander N, Bestehorn HP, et al. Randomized evaluation of the effects of fi lter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 2005; 112: 1462-9.
28. Mizote I, Ueda Y, Ohtani T, et al. Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defi ned ruptured plaque. Circulation 2005; 112: 1001-7.
29. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-903.
30. Marzilli M, Orsini E, Marraccini P, Testa R. Benefi cial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000; 101: 2154-9.
31. Ross AM, Gibbons RJ, Stone GW, et al. A randomized, doubleblinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005; 45: 1775-80.
32. Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999; 33: 654-60.
33. Ishii H, Ichimiya S, Kanashiro M, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 2005; 112: 1284-8.
34. Taniyama Y, Ito H, Iwakura K, et al. Benefi cial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997; 30: 1193-9.
35. Pasceri V, Pristipino C, Pelliccia F, et al. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol 2005; 95: 1358-61.
36. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996; 94: 2193-200.
37. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002; 106: 2881-3.
38. Bøtker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010; 375: 727-34.
39. Munk K, Andersen NH, Schmidt MR, et al. Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT. Circ Cardiovasc Imaging 2010; 3: 656-62.
40. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation 2005; 112: 2143-8.
41. Thuny F, Lairez O, Roubille F, et al. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2012; 59: 2175-81.